EM Imaging Ltd. With a strong focus on molecular targeting technology, they enable real-time disease detection and intervention, offering more precise treatment options while minimizing damage to healthy tissue. Their team possesses decades of expertise in imaging agents and therapeutics discovery and development, covering areas like medicinal chemistry, radiochemistry, biochemistry, and cell biology.

In addition to having a deep understanding of clinical development and approval processes, EM Imaging is dedicated to becoming a leader in providing cost-effective and accessible targeted fluorescent optical imaging and therapy agents. The company's products and services involve the discovery and development of small molecules and peptides that bind specifically to cancerous cells and diseased tissues when combined with fluorescent dyes or radionuclides. This innovative approach provides clinicians with a clearer view of disease extent, empowering them to make more informed decisions for the benefit of their patients